Burcon NutraScience Corporation, together with its subsidiary, develops plant protein extraction and purification technology of functional and renewable plant proteins in Canada. Its products include CLARISOY, a soy protein for dairy foods, neutral pH beverages, and coffee creamers/whiteners; and Peazazz, a novel pea protein isolate. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation was founded in 1998 and is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Stock Exchange TSE
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolTSE:BU
Previous Symbol
CUSIPN/A
Phone+1-604-7330896
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-10,747.86%
Return on Equity-630.98%
Return on Assets-159.82%
Miscellaneous
EmployeesN/A
Outstanding Shares43,942,000
Market CapC$22.70 million
OptionableN/A
Burcon NutraScience (TSE:BU) Frequently Asked Questions
What is Burcon NutraScience's stock symbol?
Burcon NutraScience trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BU."
How were Burcon NutraScience's earnings last quarter?
Burcon NutraScience Corp (TSE:BU) posted its quarterly earnings data on Friday, August, 10th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $0.01 million for the quarter. Burcon NutraScience had a negative net margin of 10,747.86% and a negative return on equity of 630.98%. View Burcon NutraScience's Earnings History.
When is Burcon NutraScience's next earnings date?
Who are some of Burcon NutraScience's key competitors?
Some companies that are related to Burcon NutraScience include 4d Pharma (DDDD), Helix Biopharma (HBP), Ergomed (ERGO), Cardiome Pharma (COM), GB Sciences (GBLX), OncoCyte (OCX), InMed Pharmaceuticals (IMLFF), Navidea Biopharmaceuticals (NAVB), Botanix Pharmaceuticals (BOT), IntelGenx Technologies (IGX), BELLUS Health (BLU), Medicenna Therapeutics (MDNA), Destiny Pharma (DEST), NovaBay Pharmaceuticals (NBY) and Rexahn Pharmaceuticals (RNN).
Who are Burcon NutraScience's key executives?
Burcon NutraScience's management team includes the folowing people:
- Dr. Allan Yap, Chairman & CEO (Age 62)
- Mr. Johann Franz Tergesen MBA, CPA, CA, Pres & COO (Age 55)
- Ms. Jade Cheng MBA, CPA, CA, CFO & Treasurer
- Ms. Kam T. Law, Sr. VP of Legal & Corp. Sec. (Age 49)
- Mr. Randy Willardsen MSc, Sr. VP of Process
How do I buy shares of Burcon NutraScience?
Shares of BU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Burcon NutraScience's stock price today?
One share of BU stock can currently be purchased for approximately C$0.36.
How big of a company is Burcon NutraScience?
Burcon NutraScience has a market capitalization of C$22.70 million.
What is Burcon NutraScience's official website?
How can I contact Burcon NutraScience?
Burcon NutraScience's mailing address is 1946 Broadway W, VANCOUVER, BC V6J 1Z2, Canada. The company can be reached via phone at +1-604-7330896.
MarketBeat Community Rating for Burcon NutraScience (TSE BU)
MarketBeat's community ratings are surveys of what our community members think about Burcon NutraScience and other stocks. Vote "Outperform" if you believe BU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BU will underperform the S&P 500 over the long term. You may vote once every thirty days.
